Literature DB >> 21593145

Nipah virus uses leukocytes for efficient dissemination within a host.

Cyrille Mathieu1, Christine Pohl, Judit Szecsi, Selena Trajkovic-Bodennec, Séverine Devergnas, Hervé Raoul, François-Loïc Cosset, Denis Gerlier, T Fabian Wild, Branka Horvat.   

Abstract

Nipah virus (NiV) is a recently emerged zoonotic paramyxovirus whose natural reservoirs are several species of Pteropus fruit bats. NiV provokes a widespread vasculitis often associated with severe encephalitis, with up to 75% mortality in humans. We have analyzed the pathogenesis of NiV infection, using human leukocyte cultures and the hamster animal model, which closely reproduces human NiV infection. We report that human lymphocytes and monocytes are not permissive for NiV and a low level of virus replication is detected only in dendritic cells. Interestingly, despite the absence of infection, lymphocytes could efficiently bind NiV and transfer infection to endothelial and Vero cells. This lymphocyte-mediated transinfection was inhibited after proteolytic digestion and neutralization by NiV-specific antibodies, suggesting that cells could transfer infectious virus to other permissive cells without the requirement for NiV internalization. In NiV-infected hamsters, leukocytes captured and carried NiV after intraperitoneal infection without themselves being productively infected. Such NiV-loaded mononuclear leukocytes transfer lethal NiV infection into naïve animals, demonstrating efficient virus transinfection in vivo. Altogether, these results reveal a remarkable capacity of NiV to hijack leukocytes as vehicles to transinfect host cells and spread the virus throughout the organism. This mode of virus transmission represents a rapid and potent method of NiV dissemination, which may contribute to its high pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593145      PMCID: PMC3147937          DOI: 10.1128/JVI.00549-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Isolation of Nipah virus from Malaysian Island flying-foxes.

Authors:  Kaw Bing Chua; Chong Lek Koh; Poh Sim Hooi; Kong Fatt Wee; Jenn Hui Khong; Beng Hooi Chua; Yee Peng Chan; Mou Eng Lim; Sai Kit Lam
Journal:  Microbes Infect       Date:  2002-02       Impact factor: 2.700

2.  Nipah virus: a recently emergent deadly paramyxovirus.

Authors:  K B Chua; W J Bellini; P A Rota; B H Harcourt; A Tamin; S K Lam; T G Ksiazek; P E Rollin; S R Zaki; W Shieh; C S Goldsmith; D J Gubler; J T Roehrig; B Eaton; A R Gould; J Olson; H Field; P Daniels; A E Ling; C J Peters; L J Anderson; B W Mahy
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

3.  The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia.

Authors:  K B Chua; S K Lam; K J Goh; P S Hooi; T G Ksiazek; A Kamarulzaman; J Olson; C T Tan
Journal:  J Infect       Date:  2001-01       Impact factor: 6.072

4.  Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus.

Authors:  K N Bossart; L F Wang; B T Eaton; C C Broder
Journal:  Virology       Date:  2001-11-10       Impact factor: 3.616

5.  Generation of human pulmonary microvascular endothelial cell lines.

Authors:  V Krump-Konvalinkova; F Bittinger; R E Unger; K Peters; H A Lehr; C J Kirkpatrick
Journal:  Lab Invest       Date:  2001-12       Impact factor: 5.662

6.  Complete nucleotide sequences of Nipah virus isolates from Malaysia.

Authors:  Y P Chan; K B Chua; C L Koh; M E Lim; S K Lam
Journal:  J Gen Virol       Date:  2001-09       Impact factor: 3.891

7.  High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid.

Authors:  K B Chua; S K Lam; C T Tan; P S Hooi; K J Goh; N K Chew; K S Tan; A Kamarulzaman; K T Wong
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

8.  Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.

Authors:  D Nègre; P E Mangeot; G Duisit; S Blanchard; P O Vidalain; P Leissner; A J Winter; C Rabourdin-Combe; M Mehtali; P Moullier; J L Darlix; F L Cosset
Journal:  Gene Ther       Date:  2000-10       Impact factor: 5.250

9.  Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.

Authors:  Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Andrew C Hickey; Mark A Smith; Yee-Peng Chan; Lin-Fa Wang; Joseph J Mattapallil; Joan B Geisbert; Katharine N Bossart; Christopher C Broder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

10.  Relapsed and late-onset Nipah encephalitis.

Authors:  Chong Tin Tan; Khean Jin Goh; Kum Thong Wong; Sazilah Ahmad Sarji; Kaw Bing Chua; Nee Kong Chew; Paramsothy Murugasu; Yet Lin Loh; Heng Thay Chong; Kay Sin Tan; Tarmizi Thayaparan; Shalini Kumar; Mohd Rani Jusoh
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

View more
  49 in total

Review 1.  The immune response to Nipah virus infection.

Authors:  Joseph Prescott; Emmie de Wit; Heinz Feldmann; Vincent J Munster
Journal:  Arch Virol       Date:  2012-06-06       Impact factor: 2.574

2.  Membrane fusion-mediated autophagy induction enhances morbillivirus cell-to-cell spread.

Authors:  Sébastien Delpeut; Penny A Rudd; Patrick Labonté; Veronika von Messling
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.

Authors:  Birgit G Bradel-Tretheway; J Lizbeth Reyes Zamora; Jacquelyn A Stone; Qian Liu; Jenny Li; Hector C Aguilar
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

4.  Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.

Authors:  Abhishek N Prasad; Courtney Woolsey; Joan B Geisbert; Krystle N Agans; Viktoriya Borisevich; Daniel J Deer; Chad E Mire; Robert W Cross; Karla A Fenton; Christopher C Broder; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

5.  Twenty Years of Nipah Virus Research: Where Do We Go From Here?

Authors:  Emily S Gurley; Christina F Spiropoulou; Emmie de Wit
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

6.  HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases.

Authors:  Louis-Marie Bloyet; Jérémy Welsch; François Enchery; Cyrille Mathieu; Sylvain de Breyne; Branka Horvat; Boyan Grigorov; Denis Gerlier
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

7.  Nipah virus entry and egress from polarized epithelial cells.

Authors:  Boris Lamp; Erik Dietzel; Larissa Kolesnikova; Lucie Sauerhering; Stephanie Erbar; Hana Weingartl; Andrea Maisner
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

8.  Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence.

Authors:  Cyrille Mathieu; Vanessa Guillaume; Valentina A Volchkova; Christine Pohl; Frederique Jacquot; Ren Yih Looi; Kum Thong Wong; Catherine Legras-Lachuer; Viktor E Volchkov; Joel Lachuer; Branka Horvat
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

9.  Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.

Authors:  Hisashi Akiyama; Caitlin Miller; Hiren V Patel; Steven C Hatch; Jacob Archer; Nora-Guadalupe P Ramirez; Suryaram Gummuluru
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

10.  Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.

Authors:  Benjamin A Satterfield; Robert W Cross; Karla A Fenton; Viktoriya Borisevich; Krystle N Agans; Daniel J Deer; Jessica Graber; Christopher F Basler; Thomas W Geisbert; Chad E Mire
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.